OncLive |
ASH 2013 Preview: CAR Modified T Cells, Novel Assays, and Ibrutinib
OncLive In this phase I study being presented by Anas Younes, MD, from MSKCC, the combination of first-line ibrutinib and rituximab (R)-CHOP was explored in treatment-naive patients with CD20-positive B-cell non-Hodgkin’s lymphoma (abstract 852). According to … |
Findings from City University of Hong Kong Update Knowledge of LymphomaHispanicBusiness.comNext, under the guidance of ROR1 fluorescence, the rituximab-conjugated AFM tips were moved to cancer cells to image the cellular morphologies and detect the CD2…
|
New Stem Cells Findings from Temple University Discussed
HispanicBusiness.com MethodsWe treated 397 patients who had disease with an age-adjusted classification of high risk or high-intermediate risk with five cycles of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP plus rituximab.” Our news … |
MedscapeBiologicals Improve RA Function More Than Other DMARDsMedscapeThe trials included abatacept, adalimumab, certolizumab, etanercept, golimumab, infliximab, or rituximab compared with either nbDMARDs or placebo. The main outcome measure was improv…
|
Cell Therapeutics Reaches Pricing Agreement in Germany
Drug Discovery & Development CTI is currently accruing patients into a Phase 3 trial comparing Pixuvri and rituximab with gemcitabine and rituximab in the setting of aggressive B-cell NHL. Pixuvri does not have marketing approval in the United States. Date: December 4, 2013 … |
|
Cell Therapeutics and GKV-SV Reach Agreement on Pricing of PIXUVRI …
MarketWatch The European Medicines Agency’s (the “EMA”) Committee for Medicinal Products for Human Use has accepted PIX306, CTI’s ongoing randomized controlled Phase 3 clinical trial, which compares PIXUVRI-rituximab to gemcitabine-rituximab in patients who … |
Medscape |
Sjögren Syndrome: An A-to-Z Update
Medscape Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren’s syndrome. Ann Rheum Dis. 2007;66:351-357. Abstract. Bowman SJ, Fox RI. Classification criteria for Sjogren’s … |
Combination regimen effective in DLBCL with cardiac comorbidityHealioCombination treatment with rituximab, cyclophosphamide, vincristine, gemcitabine and prednisolone appeared active and tolerable in patients with diffuse large B-cell lymphoma who are …
Medgadget.comPrecision Oncology: Interview with Presage Biosciences Founder Dr. James OlsonMedgadget.comDr. Olson: The trial is enrolling patients with either newly diagnosed lymphomas who have not yet received treatment or relapsed lymphoma previously…
Evans syndrome associated with sterile inflammation of the central nervous …7thSpace Interactive (press release)Although treatment with rituximab was effective to normalize erythrocyte and thrombocyte levels in her peripheral blood, it failed to damp…